2017
DOI: 10.1158/0008-5472.can-17-0387
|View full text |Cite|
|
Sign up to set email alerts
|

The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized—A New Paradigm in Large-Scale Computational Research

Abstract: The Seven Bridges Cancer Genomics Cloud (CGC; www.cancergenomicscloud.org) enables researchers to rapidly access and collaborate on massive public cancer genomic datasets, including The Cancer Genome Atlas. It provides secure on-demand access to data, analysis tools and computing resources. Researchers from diverse backgrounds can easily visualize, query and explore cancer genomic datasets visually or programmatically. Data of interest can be immediately analyzed in the cloud using more than 200 pre-installed,… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
131
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 146 publications
(131 citation statements)
references
References 14 publications
0
131
0
Order By: Relevance
“…The frequencies ( Fig 1A) and total numbers (Fig EV1A) of IFNc-positive and IFNc/TNF double-positive CD8 + T cells specific for the LCMV glycoprotein (GP) epitope GP [33][34][35][36][37][38][39][40][41] were increased in spleens and livers of Trail À/À mice compared with control animals. No differences in CD4 + T cells specific for the GP epitope GP [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80] were detected (Fig EV1C), indicating that TRAIL exerts a CD8 + T cellrestricted effect on the LCMV-specific T-cell response. No differences in CD4 + T cells specific for the GP epitope GP [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75]…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The frequencies ( Fig 1A) and total numbers (Fig EV1A) of IFNc-positive and IFNc/TNF double-positive CD8 + T cells specific for the LCMV glycoprotein (GP) epitope GP [33][34][35][36][37][38][39][40][41] were increased in spleens and livers of Trail À/À mice compared with control animals. No differences in CD4 + T cells specific for the GP epitope GP [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80] were detected (Fig EV1C), indicating that TRAIL exerts a CD8 + T cellrestricted effect on the LCMV-specific T-cell response. No differences in CD4 + T cells specific for the GP epitope GP [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75]…”
Section: Resultsmentioning
confidence: 99%
“…We also observed higher frequencies of cytokineproducing CD8 + T cells specific for the H-2D b -restricted nucleoprotein (NP) epitope NP [396][397][398][399][400][401][402][403][404] in Trail À/À mice ( Fig EV1B). No differences in CD4 + T cells specific for the GP epitope GP [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80] were detected ( Fig EV1C), indicating that TRAIL exerts a CD8 + T cellrestricted effect on the LCMV-specific T-cell response. Trail À/À mice also showed reduced CD8 + T cell-mediated liver immunopathology, as measured by lower levels of serum alanine transaminase (ALT) ( Fig 1B).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…All analyses were performed on the CGC (https://cgc.sbgenomics.com/) 35 with workflows and tools implemented using Common Workflow Language. Human and mouse data were aligned to GRCh38 and mm10 assemblies, respectively.…”
Section: Computational Workflowsmentioning
confidence: 99%
“…A similar approach to sequencing analysis was later implemented by Galaxy (5), GenomicScape (6), and other platforms (3,(7)(8)(9)(10)(11)(12)(13)(14). Each of these platforms has a similar paradigm: Users upload data to a central server and apply a diverse, heterogeneous set of programs through a standardized user interface.…”
Section: Introductionmentioning
confidence: 99%